Optimizing (neo)adjuvant treatment of HER2-positive breast cancer by Reva K. Basho, Heather L. McArthur

Get full text

Aromatase inhibitor strategies in metastatic breast cancer by Heather L McArthur, Patrick G Morris

Get full text

Antibody-drug conjugates in breast cancer: overcoming resistance and boosting immune response by Hannah L. Chang, Blake Schwettmann, Heather L. McArthur, Isaac S. Chan

Get full text

Incidence and prognostic impact of HER2‐positivity loss after dual HER2‐directed neoadjuvant therapy for HER2+ breast cancer by Alexis LeVee, Kellie Spector, Brigid Larkin, Felipe Dezem, Jasmine Plummer, Farnaz Dadmanesh, Sujata Patil, Heather L. McArthur

Get full text

Risk‐reducing mastectomy decisions among women with mutations in high‐ and moderate‐ penetrance breast cancer susceptibility genes by Jacob G. Comeaux, Julie O. Culver, John E. Lee, Danielle Dondanville, Heather L. McArthur, Emily Quinn, Nicholas Gorman, Charité Ricker, Ming Li, Caryn Lerman

Get full text

Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer by Elizabeth Comen, Sadna Budhu, Yuval Elhanati, David Page, Teresa Rasalan-Ho, Erika Ritter, Phillip Wong, George Plitas, Sujata Patil, Edi Brogi, Maxine Jochelson, Yolanda Bryce, Stephen B. Solomon, Larry Norton, Taha Merghoub, Heather L. McArthur

Get full text

Digital droplet PCR analysis of organoids generated from mouse mammary tumors demonstrates proof-of-concept capture of tumor heterogeneity by Katherine E. Lake, Katherine E. Lake, Megan M. Colonnetta, Megan M. Colonnetta, Megan M. Colonnetta, Megan M. Colonnetta, Clayton A. Smith, Clayton A. Smith, Kaitlyn Saunders, Kaitlyn Saunders, Kenneth Martinez-Algarin, Kenneth Martinez-Algarin, Sakshi Mohta, Sakshi Mohta, Jacob Pena, Jacob Pena, Heather L. McArthur, Heather L. McArthur, Sangeetha M. Reddy, Sangeetha M. Reddy, Evanthia T. Roussos Torres, Elizabeth H. Chen, Elizabeth H. Chen, Elizabeth H. Chen, Elizabeth H. Chen, Isaac S. Chan, Isaac S. Chan, Isaac S. Chan, Isaac S. Chan

Get full text

TROPION-Breast04: a randomized phase III study of neoadjuvant datopotamab deruxtecan (Dato-DXd) plus durvalumab followed by adjuvant durvalumab versus standard of care in patients... by Heather L. McArthur, Sara M. Tolaney, Rebecca Dent, Peter Schmid, Jamil Asselah, Qiang Liu, Jane Lowe Meisel, Naoki Niikura, Yeon Hee Park, Gustavo Werutsky, Giampaolo Bianchini, Jay C. Andersen, Robert Kozarski, Nana Rokutanda, Barbara Pistilli, Sibylle Loibl

Get full text

Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/− trastuzumab in patients with breast cancer brain metastases by David B. Page, Kathryn Beal, Stefanie N. Linch, Kateri J. Spinelli, Micaela Rodine, Darragh Halpenny, Shanu Modi, Sujata Patil, Robert J. Young, Thomas Kaley, Taha Merghoub, David Redmond, Phillip Wong, Christopher A. Barker, Adi Diab, Larry Norton, Heather L. McArthur

Get full text

Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer by William L Redmond, David B Page, Walter J Urba, Heather L McArthur, Yoshinobu Koguchi, Valerie Conrad, Nathan Polaske, ShuChing Chang, Venkatesh Rajamanickam, Brady Bernard, Isaac Kim, Brie Chun, Joanna Pucilowska, Benjamin Nikitin, Mark Schmidt, Paul A Fields, Alison K Conlin

Get full text

A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer by David B. Page, Joanna Pucilowska, Brie Chun, Isaac Kim, Katherine Sanchez, Nicole Moxon, Staci Mellinger, Yaping Wu, Yoshinobu Koguchi, Valerie Conrad, William L. Redmond, Maritza Martel, Zhaoyu Sun, Mary B. Campbell, Alison Conlin, Anupama Acheson, Reva Basho, Philomena McAndrew, Mary El-Masry, Dorothy Park, Laura Bennetts, Robert S. Seitz, Tyler J. Nielsen, Kimberly McGregor, Venkatesh Rajamanickam, Brady Bernard, Walter J. Urba, Heather L. McArthur

Get full text